NCT00576654
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00576654
Title Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale University New Haven Connecticut 06520 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Covenant Medical Center Harrison Saginaw Michigan 48602 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field